Clinical Trial

Combined Effects of Alternate Nostril Breathing and Aerobic Interval Training on Blood Pressure and Heart Rate Products in Patients With Hypertension

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Hypertension (HTN) is the foremost preventable risk factor for cardiovascular disease (CVD) and all-cause mortality, contributing to over 7 million deaths annually within the nearly 17 million attributed to CVD. Effective management through lifestyle modifications, including aerobic exercises specifically interval training presents a promising avenue for blood pressure regulation by promoting vasodilation and regulating the autonomic nervous system. Likewise, alternate nostril breathing has demonstrated efficacy in lowering blood pressure by optimizing oxygenation and improving endothelial function but their combined effect on BP measures is yet to be determined. Hence this study aims to determine the combined effects of aerobic interval training with and without alternate nostril breathing on blood pressure, rate pressure product and quality of life in patients with hypertension.
Trial Details
NCT Number NCT07177989
Lead Sponsor Foundation University Islamabad
Conditions Hypertension (HTN)
Enrollment 36 participants
Start Date 2025-01-15
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-17